MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Spinocerebellar Ataxia Type 2 Presenting with Chorea: Korean Cases

    D. Yoo, J.Y. Lee, B. Jeon (Seoul, Republic of Korea)

    Objective: To report cases of SCA2 presenting with chorea, which have not been reported in Korea Background: Spinocerebellar ataxias (SCAs) manifest ethnic and geographical differences…
  • 2018 International Congress

    DBS neuromodulation reduces severe dystonic pain in children and young people

    S. Perides, J.P. Lin, G. Lee, H. Gimeno, R. Selway, K. Ashkan, M. Kaminska (London, United Kingdom)

    Objective: This review analyses the prevalence of painful dystonia in a cohort of children undergoing neuromodulation. The aim was to better understand the dystonic pain…
  • 2018 International Congress

    Encephalopathy in a Japanese patient with Rapid-Onset Dystonia-Parkinsonism carrying a Novel ATP1A3 mutation

    K. Hoshino, T. Kawarai, M. Hayashi, K. Kimura, Y. Nagao, M. Fukumizu, R. Miyamoto, R. Kaji (Tokyo, Japan)

    Objective: To investigate underlying pathomechanisms of DYT/PARK-ATP1A3 in Japanese patient with rapid-onset dystonia-parkinsonism (RDP). Background: Mutations in ATP1A3 would lead to development of various neurological…
  • 2018 International Congress

    Duration of response with abobotulinumtoxinA in cervical dystonia: Patient distribution results from two open label extension studies

    R. Hauser, D. Truong, M. Jog, D. Grimes, P. Picaut, A. Mann (Tampa, FL, USA)

    Objective: To report patient distribution data for duration of response with abobotulinumtoxinA (aboBoNT-A; Dysport®) from two open-label (OL) studies in patients with cervical dystonia (CD).…
  • 2018 International Congress

    Physiological effects of Botulinum Toxin therapy in Primary Cervical Dystonia

    W. Deeb, W. Hu, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To examine the physiological effects of botulinum toxin (BoNT) therapy, as measured by paired-pulse transcranial magnetic stimulation (TMS), in patients with primary cervical dystonia…
  • 2018 International Congress

    Abnormal cerebellar learning in cervical dystonia

    T. Bäumer, E. Tzvi, J. Junker, J. Verrel, S. Loens (Luebeck, Germany)

    Objective: This study was conceptualized to asses if patients with cervical dystonia (CD) exhibit deficits in cerebellar function tested by motor adaptation and motor sequence…
  • 2018 International Congress

    Neuropathology of dopa-responsive dystonia due to Tyrosine hydroxylase deficiency

    S. Schreglmann, Z. Jaunmuktane, H. Jung, C. Strand, J. Holton, K. Bhatia (London, United Kingdom)

    Objective: To describe detailed neuropathology findings from an autopsy case of dopa-responsive dystonia (DRD) with genetically confirmed tyrosine hydroxylase deficiency (THD). Background: DRD comprises a…
  • 2018 International Congress

    Underserved Patient Access to Movement Disorders Care: Experience from a Tertiary Academic Referral Center

    A. Giacobbe, E. Dinh, O. Nguyen, A. Ramirez-Zamora, M. Okun, L. Almeida (Gainesville, FL, USA)

    Objective: To explore geographical and clinic-demographical profile of underserved patients in Florida diagnosed with movement disorders. Background: Movement disorders are complex conditions that often require…
  • 2018 International Congress

    Prediction of suicidality in Huntington disease: Analysis of Enroll-HD data using machine learning approach

    Y. Seliverstov, A. Borzov, E. van Duijn, B. Landwehrmeyer, M. Belyaev (Moscow, Russian Federation)

    Objective: To develop a model for prediction of suicidal ideation or suicidal behaviour in Huntington disease gene expansion carriers (HDGEC) based on Enroll-HD data using…
  • 2018 International Congress

    Comparing risperidone and olanzapine to tetrabenazine for the management of Huntington’s chorea

    J. Schultz, J. Kamholz, P. Nopoulos, A. Killoran (Iowa City, IA, USA)

    Objective: To compare the efficacy of risperidone and olanzapine to tetrabenazine (TBZ) for the management of Huntington’s chorea in Enroll-HD participants. Background: TBZ is provenly-effective…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 177
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley